Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.

For the primary endpoint, 62.5% (40/64) of patients treated demonstrated a Complete Response ("CR") (negative cystoscopy and negative urine cytology) at any point ... non-small cell lung cancer, ...

Including patients, who demonstrated an Indeterminate Response ("IR") (negative cystoscopy and positive or suspicious urine cytology ... cancer, pancreatic cancer, leukemia, muscle invasive bladder ...

Cases of pancreatic cancer have increased significantly among younger individuals compared with those aged 35 years and older ...

Between 2000 and 2021, the incidence of pancreatic adenocarcinoma increased across all age groups, with the highest annual percentage change (APC) of 4.35% in individuals aged 15–34 years.

Eraglusib with gemcitabine and nab-paclitaxel achieved statistical significance in the first-line treatment of metastatic ...

Between 2000 and 2021, there was an increased incidence of pancreatic adenocarcinoma and a decrease in the incidence of colorectal cancer seen across age groups. HealthDay News — From 2000 to ...

Colorectal adenocarcinoma incidence is decreasing overall but increasing among individuals aged 15 to 34 years, with an APC of 1.75. Pancreatic adenocarcinoma incidence is rising across all age ...

Patients with diabetes mellitus who use GLP-1 RAs have an increased risk for acute and chronic pancreatitis, according to a study presented at DDW 2025.

The researchers identified 275,273 cases of pancreas adenocarcinoma from 2000 to 2021. The annual percentage change (APC) for pancreatic adenocarcinoma was 4.35 among those aged 15 to 34 years ...